rs876661208
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_001005373.4(LRSAM1):c.2003_2015delTGGAGGTGCAGGC(p.Leu668ProfsTer14) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. It is difficult to determine the true allele frequency of this variant because it is of type DEL_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_001005373.4 frameshift
Scores
Clinical Significance
Conservation
Publications
- Charcot-Marie-Tooth disease axonal type 2PInheritance: AR, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| LRSAM1 | NM_001005373.4 | c.2003_2015delTGGAGGTGCAGGC | p.Leu668ProfsTer14 | frameshift_variant | Exon 25 of 26 | ENST00000300417.11 | NP_001005373.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Charcot-Marie-Tooth disease axonal type 2P Pathogenic:2
- -
In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant disrupts the C-terminus of the LRSAM1 protein. Other variant(s) that disrupt this region (p.Glu674Valfs*11, p.Glu682Glyfs*5, c.2047-1G>A) have been observed in individuals with LRSAM1-related conditions (PMID: 22781092, 28286897, 29341362; Invitae). This suggests that this may be a clinically significant region of the protein. ClinVar contains an entry for this variant (Variation ID: 234769). This premature translational stop signal has been observed in individual(s) with LRSAM1-related conditions (Invitae). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Leu668Profs*14) in the LRSAM1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 56 amino acid(s) of the LRSAM1 protein. -
not provided Pathogenic:1
The c.2003_2015del13 variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. It was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The c.2003_2015del13 variant causes a frameshift starting with codon Leucine 668, changes this amino acid to a Proline residue and creates a premature Stop codon at position 14 of the new reading frame, denoted p.Leu668ProfsX14. This variant is predicted to cause loss of normal protein function through protein truncation as the last 56 amino acids of the LRSAM1 protein are lost and replaced with 13 incorrect amino acids. Therefore, this variant is likely pathogenic; however, the possibility that it is benign cannot be excluded. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at